KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) EBT Margin: 2009-2024

Historic EBT Margin for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to -9.00%.

  • Pacira BioSciences' EBT Margin rose 8768.00% to 5.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.84%, marking a year-over-year increase of 1374.00%. This contributed to the annual value of -9.00% for FY2024, which is 1814.00% down from last year.
  • According to the latest figures from FY2024, Pacira BioSciences' EBT Margin is -9.00%, which was down 198.49% from 9.14% recorded in FY2023.
  • Over the past 5 years, Pacira BioSciences' EBT Margin peaked at 10.42% during FY2021, and registered a low of -9.00% during FY2024.
  • Moreover, its 3-year median value for EBT Margin was 1.99% (2022), whereas its average is 0.71%.
  • In the last 5 years, Pacira BioSciences' EBT Margin spiked by 723bps in 2020 and then tumbled by 1,814bps in 2024.
  • Yearly analysis of 5 years shows Pacira BioSciences' EBT Margin stood at 4.68% in 2020, then surged by 574bps to 10.42% in 2021, then plummeted by 842bps to 1.99% in 2022, then skyrocketed by 715bps to 9.14% in 2023, then tumbled by 1,814bps to -9.00% in 2024.